Dr. Omid Farokzhad

Dr. Omid Farokzhad, Associate Professor of Anaesthesia, Harvard Medical School, and Director of the Laboratory of Nanomedicine and Biomaterials, Brigham and Women's Hospital

Omid Farokhzad is an Associate Professor at Harvard Medical School (HMS) and directs the Laboratory of Nanomedicine and Biomaterials at Brigham and Women's Hospital (BWH). He completed his post-doctoral clinical and research trainings, respectively, at BWH/HMS and MIT in the laboratory of Dr. Robert Langer. He received his M.D. and M.A. from Boston University School of Medicine.  Dr. Farokhzad has extensive experience with the development of therapeutic nanoparticle technologies; most notably he pioneered the high throughput combinatorial development and screening of multifunctional nanoparticles for medical applications. The technologies that Dr. Farokhzad has developed the foundation for the launch of two venture-backed biotechnology companies, BIND Biosciences and Selecta Biosciences; he serves as Director on the board of BIND and as Director and Vice Chairman on the board of Selecta. Dr. Farokhzad was named among the Nano50 winners of 2007 by Nanotech Briefs and in 2009 hewas among the 15 recipients across all industries to receive the All Star Distinguished Achievement Award, from the Mass High Tech (MHT) Journal for his contributions to Life Sciences industry.